China CITIC Financial Asset Management CoLtd (CHE) Quote

Finally progressing forward and should have full enrollment this quarter!!!

From the filing, Kenneth D. Bland, Chief Executive Officer:

https://www.otcmarkets.com/filing/html?id=17754379&guid=j3O-kHDznNizlLh

He is awful.

That is correct with Greenlane brother!! Going to live the dream with RNAZ FDA fast track rocket 10$

Govx making more of a significant move

Man, if just this one asset alone of theirs has a successful first stage or two of human clinicals, (which seems very plausible based on the completed animal testing) it immediately puts the valuation here in the hundreds of millions at a minimum. Possibly low billions. If it clears multiple stage c

https://www.otcmarkets.com/otcapi/company/financial-report/397564/content

$XONI Xtreme One Entertainment Announces Second Quarter 2024 Financial Results Marked by Continued Progress in Live Event Execution and Growth in XFC Brand
https://finance.yahoo.com/news/xtreme-one-entertainment-announces-second-203700752.html

No it isn't, click the link, it's BLEG

NOTIFICATION OF LATE FILING
Name of the Issuer: Branded Legacy Inc.
Check One: Annual Report Quarterly Report Interim Report
For Period Ended: 6/30/2024
Address of Principal Executive Office:
751 North Dr

Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)

Source

EXPERT. EXPERT. EXPERT. EXPERT.

$XONI Xtreme One Entertainment Announces Second Quarter 2024 Financial Results Marked by Continued Progress in Live Event Execution and Growth in XFC Brand
https://finance.yahoo.com/news/xtreme-one-entertainment-announces-second-203700752.html

To my understanding, I believe according to Federal Rule of Civil Procedure, a litigant has 28 days to file a motion to AMEND a judgement after a federal court enters a judgment. This rule allows a district court to correct its own errors and avoid the need for unnecessary appeals.

55% of the volume was market makers over providing liquidity to the short side for the day. Adding up all those days of greater than 40% of total volume adds up to billions of shares of market making joy.

You realize how silly you sound. You can’t have a serious discussion so you just sling mud.

That is for the wrong co. FLFR blue fire equipment inc. OTC is all screwed up

"There you go...

Misinterpreting my intent...

The "clueless factor" in some of the posts you present can be seen from a mile away. "

No, I am not misinterpreting your intent. Your intent was obvious from the day you said you were going to the Attorney G

Disappointing quarter for ELTK. Not sure why the recent run from the $9's to the $11's ahead of this report. Those buyers def didn't get an early look ha

Q2 earnings only .11/share vs .22/share last year. Operating income down an even greater %. Company blamed higher margin orders

Just my opinion but I sort of don’t like what I call the CC curse. He speaks and we drop. Again, just my opinion. Maybe today will be different. Less banter with carter. Less giggles. More serious. Like, our money is on the line type serious.

Just my opinion. Again - gr

CING $3 Patent news

Based on your skewed viewpoint of questionable and unverifiable information...

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Ftse3.mm.bing.net%2Fth%3Fid%3DOIP.uq2O8Xzk_I7gXwjGGkOnbgAAAA%26pid%3DApi&f=1&ipt=3488c9ae5e0143865921f227f2616df4b5450c497c1df05a8e332b2568061ae9&

Nasrat should address MIKAH today. Obviously this doesn’t sit well with shareholders. Why does he seem to get angry when it comes up

The worst 10Q ever !! It was all smoke and mirrors. I can’t wait to see the 3rd Qtr.
This is OTC bull$hit run by amateurs.

I think Nasrat has done an amazing job over the past decade as CEO. Wow that’s a long time. Anyways, what I wish he would not have done

Allowed the float to get to over a billion

Allow him and other insiders to own so many shares

Allow MIKAH to own

Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD